Baobab Healthcare and Pusan National University Selected for National Project on 3D Bioprinting Artificial Blood Vessels Development

[Asia Economy Reporter Minji Lee] Baobab Healthcare and the Physiology Research Team at Pusan National University College of Medicine announced on the 8th that they have been finally selected for a national project (the 1st Pan-Ministerial Regenerative Medicine Technology Development Project) to secure core technology for 3D bioprinting-based artificial vascular grafts.

This project specifically aims to produce cell- and drug-loaded bioink, fabricate cell- and drug-embedded 3D artificial arterial vessels, verify their efficacy both in vitro and in vivo, demonstrate the in vivo safety and efficacy of 3D artificial blood vessels, and develop patient-customized artificial blood vessels using induced pluripotent stem cell (iPSC)-derived vascular endothelial cells. The total project budget is 2.24 billion KRW, and the research is planned to be conducted over 4 years and 8 months.

Baobab Healthcare, a company specializing in tissue regeneration based on 3D bioprinting, stated, “This project is significant in that it can achieve a technological leap by utilizing 3D bioprinting technology in the vascular field, where unmet medical needs are substantial.” They added, “Through joint research with Professor Sangmo Kwon’s team at Pusan National University College of Medicine, who are experts in vascular disease research, we expect to accelerate the commercialization of vascular development using biocompatible bioink and nanosilica.”

This content was produced with the assistance of AI translation services.